Clinical Trial Details

EORTC-30951

Back to Clinical Trials Database

Randomized phase II trial of Interferon alpha-2a with and without 13-cis Retinoic Acid in patients with progressive metastatic renal cell carcinoma Amendment protocol: Extension to a randomized phase III trial

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 05-Mar-1996
Date Step1 close: 24-Jan-2001
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 296
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT00002737
NCT number NCT00002737